Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $91.12 | $22.86 | 298.53% | 198.09x | 156.19x | 12.37x | 15.33x | 1.41x | $119.79M | 1.26% | $637.99M | 6.11 | $9.68B | -1,410.25 | ||
| LQDA | LIQUIDIA CORP | $84.42 | $17.01 | 396.22% | 351.75x | 25.41x | 25.79x | 69.14x | 1.70x | $41.15M | 0.55% | $108.58M | 1.23 | $7.47B | 139.37 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $63.54 | $16.23 | 291.49% | 64.83x | 50.46x | 6.45x | 8.07x | 1.79x | $164.23M | 3.38% | $605.69M | 7.92 | $4.71B | 42.22 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $278.40 | $89.30 | 211.74% | 63.85x | 38.43x | 8.63x | 34.56x | 1.32x | $641.34M | 1.73% | $1.08B | 8.09 | $38.43B | 41.57 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.21 | $2.68 | 206.58% | 117.29x | 73.17x | 4.45x | 108.94x | 1.12x | $47.52M | 3.40% | $13.01M | 0.08 | $1.56B | 29.28 | ||
| HALO | HALOZYME THERAPEUTICS INC | $81.48 | $67.55 | 20.63% | 27.53x | 9.82x | 6.38x | 44.00x | 0.49x | $667.65M | 6.94% | $219.64M | 1.86 | $11.50B | 18.43 | ||
| ADMA | ADMA BIOLOGICS INC | $8.48 | $8.73 | -2.89% | 12.29x | 10.11x | 3.93x | 5.04x | 0.51x | $107.90M | 5.39% | $390.33M | 1.65 | $2.03B | 9.14 | ||
| ASND | ASCENDIS PHARMA A | $253.42 | $76.03 | 233.32% | 26.86x | 17.42x | 15.45x | 27.42x | 2.80x | $52.94M | 0.34% | $574.09M | 9.24 | $16.12B | 172.87 | ||
| KRYS | KRYSTAL BIOTECH INC | $351.82 | $87.03 | 304.26% | 45.40x | 46.13x | 24.69x | 8.12x | 2.32x | $237.38M | 2.30% | $1.28B | 43.59 | $9.88B | 46.17 | ||
| RPRX | ROYALTY PHARMA PLC | $58.73 | $38.54 | 52.38% | 30.75x | 10.94x | 10.51x | 3.40x | 0.65x | $2.34B | 9.12% | $9.94B | 22.75 | $42.19B | 36.26 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.27 | $37.24 | 61.84% | 43.05x | 16.22x | 3.58x | 1.88x | 0.64x | $767.06M | 6.61% | $6.21B | 32.27 | $10.01B | 20.74 | ||
| VCEL | VERICEL CORP | $45.32 | $8.67 | 422.73% | 105.40x | 94.01x | 7.88x | 6.50x | 2.22x | $47.49M | 2.06% | $356.23M | 7.02 | $2.30B | 56.90 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $255.43 | $46.76 | 446.22% | 543.47x | 9.89x | 3.56x | 3.54x | 1.83x | $1.30B | 8.21% | $4.53B | 73.22 | $19.58B | 29.01 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $297.50 | $97.11 | 206.34% | 37.66x | 32.20x | 21.55x | 5.98x | 1.65x | $122.22M | 2.07% | $997.32M | 50.16 | $6.30B | 27.93 | ||
| TGTX | TG THERAPEUTICS INC | $55.75 | $23.23 | 140.02% | 17.31x | 39.56x | 11.50x | 14.64x | 2.49x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.84B | 58.95 | ||
| TECH | BIO-TECHNE CORP | $71.62 | $15.89 | 350.59% | 100.87x | 34.33x | 9.25x | 5.38x | 1.85x | $269.60M | 2.41% | $2.09B | 13.34 | $11.29B | 44.12 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.01 | $33.37 | 7.90% | 14.23x | 9.49x | 2.32x | 2.29x | 0.55x | $341.79M | 16.41% | $910.35M | 15.75 | $1.65B | 6.98 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.18 | $8.52 | -86.15% | 4.37x | -3.99x | 1.10x | 1.29x | 0.05x | $7.24M | 10.68% | $52.93M | 0.92 | $14.67M | 0.95 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $479.00 | $157.46 | 204.21% | 28.16x | 24.77x | 9.96x | 6.28x | 2.11x | $3.71B | 3.05% | $19.36B | 76.20 | $118.07B | 21.89 | ||
| UTHR | UNITED THERAPEUTICS CORP | $527.94 | $226.52 | 133.07% | 18.03x | 19.29x | 7.25x | 3.80x | 2.10x | $1.02B | 4.43% | $5.90B | 135.66 | $21.13B | 12.33 | ||
| EXEL | EXELIXIS INC | $55.81 | $28.84 | 93.54% | 17.89x | 17.35x | 6.07x | 7.25x | 1.34x | $917.69M | 6.36% | $1.94B | 7.49 | $13.97B | 13.23 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.23 | $1.95 | 65.77% | 13.46x | 13.97x | 1.98x | 3.12x | 1.38x | $4.11M | 1.58% | $82.33M | 1.03 | $193.28M | 9.10 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $667.17 | $411.87 | 61.98% | 15.68x | 14.29x | 4.65x | 2.23x | 1.07x | $4.11B | 5.93% | $31.42B | 302.15 | $69.69B | 12.13 | ||
| VCYT | VERACYTE INC | $55.61 | $8.56 | 549.97% | 50.10x | 50.15x | 8.16x | 3.30x | 5.90x | $155.34M | 3.51% | $1.34B | 16.90 | $4.21B | 36.61 | ||
| INCY | INCYTE CORP | $118.87 | $62.97 | 88.77% | 16.31x | 15.64x | 4.42x | 4.22x | 1.43x | $1.45B | 6.12% | $5.62B | 28.21 | $20.32B | 10.86 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.